{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T06:48:48Z","timestamp":1768805328134,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T00:00:00Z","timestamp":1515024000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Merck Investigator Studies Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s40258-017-0367-1","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T22:21:32Z","timestamp":1515018092000},"page":"195-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Direct Medical Costs of Diseases Associated with Human Papillomavirus Infection in Manitoba, Canada"],"prefix":"10.1007","volume":"16","author":[{"given":"Christiaan H.","family":"Righolt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurpreet","family":"Pabla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6574-0574","authenticated-orcid":false,"given":"Salaheddin M.","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,4]]},"reference":[{"issue":"Suppl 1","key":"367_CR1","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.jcv.2004.12.008","volume":"32","author":"JG Baseman","year":"2005","unstructured":"Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005;32(Suppl 1):S16\u201324. https:\/\/doi.org\/10.1016\/j.jcv.2004.12.008.","journal-title":"J Clin Virol"},{"issue":"1","key":"367_CR2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1363\/3600604","volume":"36","author":"H Weinstock","year":"2004","unstructured":"Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36(1):6\u201310.","journal-title":"Perspect Sex Reprod Health."},{"issue":"7","key":"367_CR3","first-page":"1017","volume":"164","author":"EL Franco","year":"2001","unstructured":"Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ. 2001;164(7):1017\u201325.","journal-title":"CMAJ"},{"key":"367_CR4","volume-title":"Human papillomaviruses. IARC Monographs on the evaluation of the carcinogenic risks to humans","author":"IARC Working Group","year":"1995","unstructured":"IARC Working Group. Human papillomaviruses. IARC Monographs on the evaluation of the carcinogenic risks to humans. Lyon: International Agency for Research on Cancer; 1995."},{"issue":"9","key":"367_CR5","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","volume":"4","author":"M Plummer","year":"2016","unstructured":"Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Global Health. 2016;4(9):e609\u201316. https:\/\/doi.org\/10.1016\/S2214-109X(16)30143-7.","journal-title":"Lancet Global Health"},{"issue":"6","key":"367_CR6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518\u201327. https:\/\/doi.org\/10.1056\/NEJMoa021641.","journal-title":"N Engl J Med"},{"issue":"4","key":"367_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10552-008-9276-9","volume":"20","author":"DM Backes","year":"2009","unstructured":"Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control. 2009;20(4):449\u201357. https:\/\/doi.org\/10.1007\/s10552-008-9276-9.","journal-title":"Cancer Causes Control"},{"issue":"7","key":"367_CR8","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/ijc.24116","volume":"124","author":"H Vuyst De","year":"2009","unstructured":"De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009;124(7):1626\u201336. https:\/\/doi.org\/10.1002\/ijc.24116.","journal-title":"Int J Cancer"},{"issue":"Suppl 5","key":"367_CR9","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","volume":"30","author":"D Forman","year":"2012","unstructured":"Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(Suppl 5):F12\u201323. https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.055.","journal-title":"Vaccine"},{"issue":"16","key":"367_CR10","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1016\/j.ejca.2013.06.033","volume":"49","author":"S Sanjos\u00e9 de","year":"2013","unstructured":"de Sanjos\u00e9 S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2013;49(16):3450\u201361. https:\/\/doi.org\/10.1016\/j.ejca.2013.06.033.","journal-title":"Eur J Cancer"},{"key":"367_CR11","unstructured":"CDC. Pinkbook: Human Papillomavirus Chapter\u2014Epidemiology of Vaccine-Preventable Diseases. 2015. CDC\u2014Pinkbook: Human Papillomavirus Chapter\u2014Epidemiology of Vaccine-Preventable Diseases. 2015. http:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/hpv.html. Accessed 06 April 2015."},{"issue":"1","key":"367_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ijc.28963","volume":"136","author":"L Alemany","year":"2015","unstructured":"Alemany L, Saunier M, Alvarado-Cabrero I, Quir\u00f3s B, Salmeron J, Shin H-R, et al. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer. 2015;136(1):98\u2013107. https:\/\/doi.org\/10.1002\/ijc.28963.","journal-title":"Int J Cancer"},{"issue":"6","key":"367_CR13","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.arcmed.2009.06.003","volume":"40","author":"EL Franco","year":"2009","unstructured":"Franco EL, Mahmud SM, Tota J, Ferenczy A, Coutl\u00e9e F. The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change. Arch Med Res. 2009;40(6):478\u201385. https:\/\/doi.org\/10.1016\/j.arcmed.2009.06.003.","journal-title":"Arch Med Res"},{"issue":"11","key":"367_CR14","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2165\/00019053-200523110-00004","volume":"23","author":"R Insinga","year":"2005","unstructured":"Insinga R, Dasbach E, Elbasha E. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US. Pharmacoeconomics. 2005;23(11):1107\u201322. https:\/\/doi.org\/10.2165\/00019053-200523110-00004.","journal-title":"Pharmacoeconomics"},{"key":"367_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.02.011","author":"DR Lairson","year":"2017","unstructured":"Lairson DR, Fu S, Chan W, Xu L, Shelal Z, Ramondetta L. Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas. Gynecol Oncol. 2017. https:\/\/doi.org\/10.1016\/j.ygyno.2017.02.011.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"367_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ajog.2004.01.042","volume":"191","author":"RP Insinga","year":"2004","unstructured":"Insinga RP, Glass AG, Rush BB. The health care costs of cervical human papillomavirus\u2013related disease. Am J Obstet Gynecol. 2004;191(1):114\u201320. https:\/\/doi.org\/10.1016\/j.ajog.2004.01.042.","journal-title":"Am J Obstet Gynecol"},{"issue":"42","key":"367_CR17","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1016\/j.vaccine.2012.07.056","volume":"30","author":"HW Chesson","year":"2012","unstructured":"Chesson HW, Ekwueme DU, Saraiya M, Watson M, Lowy DR, Markowitz LE. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine. 2012;30(42):6016\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.056.","journal-title":"Vaccine"},{"issue":"7","key":"367_CR18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00005650-199907000-00005","volume":"37","author":"LJ Helms","year":"1999","unstructured":"Helms LJ, Melnikow J. Determining costs of health care services for cost-effectiveness analyses: the case of cervical cancer prevention and treatment. Med Care. 1999;37(7):652\u201361.","journal-title":"Med Care"},{"issue":"19","key":"367_CR19","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1016\/j.vaccine.2004.10.029","volume":"23","author":"LJ Erickson","year":"2005","unstructured":"Erickson LJ, De Wals P, Farand L. An analytical framework for immunization programs in Canada. Vaccine. 2005;23(19):2470\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2004.10.029.","journal-title":"Vaccine"},{"issue":"8","key":"367_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1405044","volume":"372","author":"EA Joura","year":"2015","unstructured":"Joura EA, Giuliano AR, Iversen O-E, Bouchard C, Mao C, Mehlsen J, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;372(8):711\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1405044.","journal-title":"N Engl J Med"},{"issue":"3","key":"367_CR21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00005650-199303000-00002","volume":"31","author":"L Roos","year":"1993","unstructured":"Roos L, Mustard C, Nicol J, McLerran D, Malenka D, Young T, et al. Registries and administrative data: organization and accuracy. Med Care. 1993;31(3):201\u201312.","journal-title":"Med Care"},{"issue":"11","key":"367_CR22","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1345\/aph.18117","volume":"32","author":"AL Kozyrskyj","year":"1998","unstructured":"Kozyrskyj AL, Mustard CA. Validation of an electronic, population-based prescription database. Ann Pharmacother. 1998;32(11):1152\u20137. https:\/\/doi.org\/10.1345\/aph.18117.","journal-title":"Ann Pharmacother"},{"issue":"9","key":"367_CR23","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/00005650-199709000-00006","volume":"35","author":"JR Robinson","year":"1997","unstructured":"Robinson JR, Young TK, Roos LL, Gelskey DE. Estimating the burden of disease: comparing administrative data and self-reports. Med Care. 1997;35(9):932\u201347.","journal-title":"Med Care"},{"issue":"6\u20137","key":"367_CR24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-0463.2010.02619.x","volume":"118","author":"DA Larson","year":"2010","unstructured":"Larson DA, Derkay CS. Epidemiology of recurrent respiratory papillomatosis. Apmis. 2010;118(6\u20137):450\u20134.","journal-title":"Apmis"},{"issue":"5","key":"367_CR25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1200\/jco.2013.52.4645","volume":"32","author":"SM Mahmud","year":"2014","unstructured":"Mahmud SM, Kliewer EV, Lambert P, Bozat-Emre S, Demers AA. Effectiveness of the quadrivalent human papillomavirus vaccine against cervical dysplasia in Manitoba, Canada. J Clin Oncol. 2014;32(5):438\u201343. https:\/\/doi.org\/10.1200\/jco.2013.52.4645.","journal-title":"J Clin Oncol"},{"issue":"6","key":"367_CR26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/OLQ.0b013e318198de8c","volume":"36","author":"EV Kliewer","year":"2009","unstructured":"Kliewer EV, Demers AA, Elliott L, Lotocki R, Butler JR, Brisson M. Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada. Sex Transm Dis. 2009;36(6):380\u20136. https:\/\/doi.org\/10.1097\/OLQ.0b013e318198de8c.","journal-title":"Sex Transm Dis"},{"key":"367_CR27","unstructured":"Canadian Cancer Statistics 2016. Toronto: Canadian Cancer Society\u2019s Advisory Committee on Cancer Statistics; 2016. http:\/\/www.cancer.ca\/~\/media\/cancer.ca\/CW\/cancer%20information\/cancer%20101\/Canadian%20cancer%20statistics\/Canadian-Cancer-Statistics-2016-EN.pdf?la=en. Accessed 10 Oct 2017."},{"key":"367_CR28","unstructured":"Finlayson GS, Ekuma O, Yogendran M, Burland E, Forget E. The Additional Cost of Chronic Disease in Manitoba. Winnipeg; 2010. https:\/\/www.researchgate.net\/publication\/275649026_Chronic_Disease_in_Manitoba_What_are_the_costs_Winnipeg_Manitoba_Centre_for_Health_Policy. Accessed 10 Aug 2017."},{"issue":"3","key":"367_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/OLQ.0b013e318285c6d2","volume":"40","author":"K Owusu-Edusei Jr","year":"2013","unstructured":"Owusu-Edusei K Jr, Chesson HW, Gift TL, Tao G, Mahajan R, Ocfemia MC, et al. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis. 2013;40(3):197\u2013201. https:\/\/doi.org\/10.1097\/OLQ.0b013e318285c6d2.","journal-title":"Sex Transm Dis"},{"key":"367_CR30","unstructured":"OECD. Health expenditure indicators. http:\/\/www.oecd-ilibrary.org\/social-issues-migration-health\/data\/oecd-health-statistics\/system-of-health-accounts-health-expenditure-by-function_data-00349-en. Accessed 4 Sept 2017."},{"issue":"11","key":"367_CR31","doi-asserted-by":"publisher","first-page":"e49699","DOI":"10.1371\/journal.pone.0049699","volume":"7","author":"G Baio","year":"2012","unstructured":"Baio G, Capone A, Marcellusi A, Mennini FS, Favato G. Economic burden of human papillomavirus-related diseases in Italy. PLoS One. 2012;7(11):e49699. https:\/\/doi.org\/10.1371\/journal.pone.0049699.","journal-title":"PLoS One"},{"issue":"32","key":"367_CR32","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1016\/j.vaccine.2011.05.018","volume":"29","author":"I Borget","year":"2011","unstructured":"Borget I, Abramowitz L, Mathevet P. Economic burden of HPV-related cancers in France. Vaccine. 2011;29(32):5245\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.018.","journal-title":"Vaccine"},{"issue":"1","key":"367_CR33","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.9778\/cmajo.20120013","volume":"1","author":"C Oliveira de","year":"2013","unstructured":"de Oliveira C, Bremner KE, Pataky R, Gunraj N, Chan K, Peacock S, et al. Understanding the costs of cancer care before and after diagnosis for the 21 most common cancers in Ontario: a population-based descriptive study. CMAJ Open. 2013;1(1):E1\u20138. https:\/\/doi.org\/10.9778\/cmajo.20120013.","journal-title":"CMAJ Open"},{"key":"367_CR34","doi-asserted-by":"publisher","unstructured":"Cromwell I, Ferreira Z, Smith L, van der Hoek K, Ogilvie G, Coldman A et al. Cost and resource utilization in cervical cancer management: a real-world retrospective cost analysis. Curr Oncol (Tor Ont). 2016;23(Suppl 1):S14\u2013S22. https:\/\/doi.org\/10.3747\/co.23.2914.","DOI":"10.3747\/co.23.2914"},{"issue":"2","key":"367_CR35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ygyno.2008.07.032","volume":"111","author":"RP Insinga","year":"2008","unstructured":"Insinga RP, Ye X, Singhal PK, Carides GW. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large US health plan. Gynecol Oncol. 2008;111(2):188\u201396. https:\/\/doi.org\/10.1016\/j.ygyno.2008.07.032.","journal-title":"Gynecol Oncol"},{"key":"367_CR36","volume-title":"Evaluation of cervical cytology. Evidence report\/technology assessment No. 5","author":"D McCrory","year":"1999","unstructured":"McCrory D, Matchar D, Bastian L, Datta S, Hasselblad V, Hickey J. Evaluation of cervical cytology. Evidence report\/technology assessment No. 5. Rockville: Agency for Health Care Policy and Research; 1999."},{"issue":"1","key":"367_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3111\/13696990801961611","volume":"11","author":"L Annemans","year":"2008","unstructured":"Annemans L, R\u00e9my V, Lamure E, Spaepen E, Lamotte M, Muchada J-P, et al. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium. J Med Econ. 2008;11(1):135\u201350. https:\/\/doi.org\/10.3111\/13696990801961611.","journal-title":"J Med Econ"},{"issue":"1","key":"367_CR38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7314\/APJCP.2012.13.1.305","volume":"13","author":"JJ Low","year":"2012","unstructured":"Low JJ, Ko Y, Ilancheran A, Zhang XH, Singhal PK, Tay SK. Health and economic burden of HPV-related diseases in Singapore. Asian Pac J Cancer Prev. 2012;13(1):305\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"367_CR39","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jnci\/djh104","volume":"96","author":"SJ Goldie","year":"2004","unstructured":"Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, Bosch FX, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16\/18 vaccine. J Natl Cancer Inst. 2004;96(8):604\u201315.","journal-title":"J Natl Cancer Inst"},{"key":"367_CR40","unstructured":"Copeland G, Lake A, Firth R, Wohler B, Wu X-C, Schymura MJ et al. Cancer in North America: 2009-2013. Volume One: Combined Cancer Incidence for the United States, Canada and North America; 2016."}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40258-017-0367-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-017-0367-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-017-0367-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T11:35:45Z","timestamp":1522236945000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40258-017-0367-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["367"],"URL":"https:\/\/doi.org\/10.1007\/s40258-017-0367-1","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,4]]}}}